Status:
COMPLETED
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Lead Sponsor:
Bagcilar Training and Research Hospital
Conditions:
Endometriosis
Eligibility:
FEMALE
18-50 years
Brief Summary
The diagnostic value of Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and Proinflammatory cytokines (TNF-a and interleukin-6) in ovarian endometriosis and deep infiltrating endometri...
Detailed Description
Serum Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and proinflammatory cytokines (TNF-a and interleukin-6) values were studied by taking blood samples from all patients before and t...
Eligibility Criteria
Inclusion
- 1\. Stage III and IV endometriosis patients requiring surgery due to chronic pelvic pain or suspected malignancy
Exclusion
- Malignant disease
- Ovarian failure
- Acute pelvic inflammatory disease
- Smokers
- Pregnancy
- Chronic autoimmune disease
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT05312528
Start Date
February 1 2018
End Date
March 1 2019
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bagcilar Teaching and Research Hospital
Istanbul, Bagcilar, Turkey (Türkiye), 34200